Regeneron Pharmaceuticals Inc. (REGN) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer
Regeneron Pharmaceuticals Inc. (REGN) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
REGN Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING
Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (REGN)
No recent open-market Form 4 cluster sales or emergency dumps flagged on REGN. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live REGN Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
REGN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +1.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on REGN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for REGN. Explore sector supply chains on /butterfly.
REGN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDAre REGN insiders and hedge funds buying or selling?
Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies REGN leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.